Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2018 1
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Health Care Costs and Cost-effectiveness in Laryngotracheal Stenosis.
Yin LX, Padula WV, Gadkaree S, Motz K, Rahman S, Predmore Z, Gelbard A, Hillel AT. Yin LX, et al. Otolaryngol Head Neck Surg. 2019 Apr;160(4):679-686. doi: 10.1177/0194599818815068. Epub 2018 Nov 27. Otolaryngol Head Neck Surg. 2019. PMID: 30481123 Free PMC article.
OBJECTIVE: Laryngotracheal stenosis (LTS) is resource-intensive disease. The cost-effectiveness of LTS treatments has not been adequately explored. ...RESULTS: Mean LTS costs were $4080.09 (SE, $569.29) annually for related health care
OBJECTIVE: Laryngotracheal stenosis (LTS) is resource-intensive disease. The cost-effectiveness of LTS treatment …
Mitomycin-c application in airway stenosis surgery: analysis of safety and costs.
Ubell ML, Ettema SL, Toohill RJ, Simpson CB, Merati AL. Ubell ML, et al. Otolaryngol Head Neck Surg. 2006 Mar;134(3):403-6. doi: 10.1016/j.otohns.2005.10.057. Otolaryngol Head Neck Surg. 2006. PMID: 16500435
OBJECTIVE: This study describes a large series of patients receiving topical mitomycin-c (MMC) during airway surgery, including complications, and carries out a cost analysis for its use in laryngotracheal stenosis. ...Airway patients receiving MMC are …
OBJECTIVE: This study describes a large series of patients receiving topical mitomycin-c (MMC) during airway surgery, including complication …
Feedback